SEC Filing Update: #KPRX Kiora Pharmaceuticals, Inc. : $2.58

Sector: Healthcare | YTD: 🔼+ 25.85% The SEC disclosed Today (17-SEP-2026) that Baselake Partners, LP has Newly bought 257,500 #KPRX shares Ownership: 5.8% * Estimated Investment Value: $664.35K https://www.thinksabio.com/reports/isr/KPRX Institutional ownership in #KPRX has been steadily rising over the past 2 quarters in Shares: Q1 2026: 339.20K Q2 2026: 1.11M The quarterly average prices of #KPRX: Q2 2026: $2.52 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2100687715675124097 Baselake Partners, LP acquired 257,500 shares of KPRX, establishing a 5.8% ownership stake in the healthcare sector company.